Thiotepa versus Bacille Calmette-Guérin in Non-Muscle Invasive Bladder Cancer

Publisher： Karger

E-ISSN： 1661-7657|6|3|160-164

ISSN： 1661-7649

Source： Current Urology, Vol.6, Iss.3, 2012-12, pp. : 160-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non Muscle Invasive Bladder Cancer Cases Initially Failing to Respond to Bacillus Calmette-Guérin Intravesical Instillation Therapy

By  

Current Urology, Vol. 4, Iss. 1, 2010-01 ,pp. : 18-24

Karger

Access to resources Recommend Favorite

Intravesical bacillus Calmette–Guérin instillation in non‐muscle‐invasive bladder cancer: A review

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 18-24

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and Efficacy of Intravesical Bacillus Calmette-Guérin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria: A Systematic Review

By  

Urologia Internationalis, Vol. 99, Iss. 1, 2017-06 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

A Six-Week Course of Bacillus Calmette-Guérin Prophylaxis Is Insufficient to Prevent Tumor Recurrence in Nonmuscle Invasive Bladder Cancer with Strong-Positive Expression of p53

By  

Oncology, Vol. 79, Iss. 5-6, 2011-04 ,pp. : 440-446

Karger

Access to resources Recommend Favorite

Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high‐risk non‐muscle‐invasive bladder cancer treated with maintenance intravesical Bacillus Calmette‐Guérin

By  

BJU INTERNATIONAL, Vol. 116, Iss. 5, 2015-11 ,pp. : 721-726

John Wiley & Sons Inc

Access to resources Recommend Favorite